Yangming Zhang

Chinese Academy of Sciences

H指数:26

被引数:2,691

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An automated operon refactoring workflow for heterologous expression of non-ribosomal peptide biosynthetic gene clusters

用于异源表达非核糖体肽生物合成基因簇的自动化操纵子重构工作流程

Nature Communications

IF15.7

2026-10-110

OAAI

Adhesive Tape-Inspired Polymer Coatings Enable Record-Stable Zinc Anodes for High-Rate Aqueous Batteries

受胶带启发的聚合物涂层为高倍率水性电池提供了创纪录的稳定锌阳极

ADVANCED SCIENCE

IF14.1

2025-12-010

OAAI

Effects of Early-Life Tactile Experience Enrichment on Autistic-Like Behaviors and Synaptic Alterations in Shank3 Mutant Mice

早期触觉经验丰富对Shank3突变小鼠自闭症样行为及突触改变的影响

Fundamental Research

IF6.3

2025-09-200

OAAI

Durability Analysis of Brick-Faced Clay-Core Walls in Traditional Residential Architecture in Quanzhou, China

中国泉州传统住宅建筑中砖面粘土芯墙的耐久性分析

coatings

IF0

2025-08-170

A multi-objective optimization study on the electromechanical system for a space mechanism based on a Catboost surrogate model and NSGA-III algorithm

基于Catboost代理模型和NSGA-III算法的空间机构机电系统多目标优化研究

EXPERT SYSTEMS WITH APPLICATIONS

IF7.5

2025-04-010

PRE

PRR13 expression as a prognostic biomarker in breast cancer: correlations with immune infiltration and clinical outcomes

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2025-03-030

OAAI

Simultaneous determination of BGT-002 and its acyl glucuronide metabolite ZM326E-M2 in human plasma by liquid chromatography-tandem mass spectrometry and its application to a pharmacokinetic study

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS

IF3.1

2024-06-011

PRE

Chiral Iridium-Based TLD-1433 Analogues: Exploration of Enantiomer-Dependent Behavior in Photodynamic Cancer Therapy

INORGANIC CHEMISTRY

IF4.7

2024-04-156

PRE

Elucidation of genes enhancing natural product biosynthesis through co-evolution analysis

NATURE METABOLISM

IF20.8

2024-04-125

CB1R dysfunction of inhibitory synapses in the ACC drives chronic social isolation stress-induced social impairments in male mice

NEURON

IF15

2024-02-015

PRE

Biomedical applications of multinuclear Pt(II)/Ru(II)/Ir(III) metallo-supramolecular assemblies for intensive cancer therapy

COORDINATION CHEMISTRY REVIEWS

IF23.5

2023-11-019

PRE

GPR84 regulates pulmonary inflammation by modulating neutrophil functions

ACTA PHARMACOLOGICA SINICA

IF8.4

2023-04-0416

OAAI

Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia

开发新型ACLY抑制剂326E作为高胆固醇血症的有希望的治疗方法

ACTA PHARMACEUTICA SINICA B

IF14.6

2023-02-0122

OAAI

Targeting Mitochondrial Sirtuins in Age-Related Neurodegenerative Diseases and Fibrosis

在年龄相关的神经退行性疾病和纤维化中靶向线粒体Sirtuins

AGING AND DISEASE

IF6.9

2023-01-017

OAAI

The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKK? and overcomes gefitinib resistance in non-small cell lung cancer

HDAC抑制剂GCJ-490A通过IKK抑制c-met表达？并克服非小细胞肺癌吉非替尼耐药

CANCER BIOLOGY & MEDICINE

IF8.4

2022-07-157

OAAI

Disruption of adipocyte HIF-1α improves atherosclerosis through the inhibition of ceramide generation

破坏脂肪细胞HIF-1α 通过抑制神经酰胺生成改善动脉粥样硬化

ACTA PHARMACEUTICA SINICA B

IF14.6

2022-04-0123

OAAI

Dephosphorylation of AMP-activated protein kinase exacerbates ischemia/reperfusion-induced acute kidney injury via mitochondrial dysfunction

KIDNEY INTERNATIONAL

IF12.6

2022-02-0180

Human Microbiome and Its Medical Applications

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2022-01-139

OAAI

GPR84 signaling promotes intestinal mucosal inflammation via enhancing NLRP3 inflammasome activation in macrophages

GPR84信号通过增强巨噬细胞NLRP3炎性体活化促进肠黏膜炎症

ACTA PHARMACOLOGICA SINICA

IF8.4

2021-12-1539

OAAI

T4SEfinder: a bioinformatics tool for genome-scale prediction of bacterial type IV secreted effectors using pre-trained protein language model

BRIEFINGS IN BIOINFORMATICS

IF7.7

2021-10-1517

PRE

Yangming Zhang

个人简介

教育背景

工作经历

荣誉奖项

研究方向